Review of Andlauer Healthcare Group Inc.

JUL 16, 2024 - We believe AND will continue to benefit from the long-term secular growth trends in the healthcare transportation market, and growth in its US business can help fuel top and bottom-line growth. For now, it’s a fundamentally-sound company trading at slightly premium valuations, and with somewhat flat year-over-year growth. We believe it has better long-term prospects, and for now, we are maintaining our rating at a ‘B’.

Download Report

Q: I’ve always had less than positive results investing in the healthcare sector. Finally I decided to go with an ETF (XHC) to do away with the individual stock picking risk which has since declined as well. I am now thinking of sticking with “healthcare adjacent” companies since SIS (currently owned) has done well for me. Can you please comment on SIA, CSH, and AND, the first two have run up a bit recently and I wonder about their valuations and future prospects. Any other candidates that might fit the bill you could recommend, I know choices in Canada are slim?

Read Answer Asked by Stephen R. on November 21, 2024

Q: What is your outlook for ECN and AND and why ? I'm thinking of selling one or both to finance a purchase of ISRG ........

Read Answer Asked by Garth on November 14, 2024

Q: After signing up to the Portfolio Tracking & Analysis, ( excellent service, Thanks!)
I need to increase my holdings in the Health care sector and Consumer Defensive industry
US and Can exposure.
Your suggestions are appreciated.
Thank You 5i Team
Heidi

Read Answer Asked by Adelheid on October 18, 2024